| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.096 | 0.09 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.076 | 0.09 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.1 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.088 | 0.1 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |